Voltage-Gated Potassium Channel (VGKC) Antibodies
Voltage-Gated Potassium Channel (VGKC) Antibodies, Serum
Test
Method
Radioimmunoassay (RIA)
Report Includes
Specimens
Serum
Clinical Utility
Voltage-Gated Potassium Channel (VGKC) Antibody – Limbic encephalitis (LE) is a paraneoplastic neurological syndrome often associated with small cell lung carcinoma and more rarely with testicular, breast, and other tumors. Clinical hallmarks of paraneoplastic limbic encephalitis are changing mental status, short-term memory impairment, seizures, confusion, and behavioral changes. Hu antibody-negative LE patients usually do not develop symptoms beyond the limbic system and appear to improve more often after treatment of the cancer than those who have Hu antibodies, suggesting that the pathogenesis of the LE in both groups could be different. Recent studies have detected antibodies to voltage-gated potassium channels (VGKC) in patients with LE, with and without associated tumors. Neurological symptoms were found to improve with a reduction of VGKC antibody levels.
Test Location
Quest Diagnostics, California USA
Test Version
28-Nov-2019
Specimen
Specimens
Serum
Sample Volume
1.0 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send frozen
Stability
Ambient | 48 hours |
---|---|
Refrigerated | 48 hours |
Frozen | 73 days |
Test Version
28-Nov-2019
Performance / Interpretation
Method
Radioimmunoassay (RIA)
Turnaround Time
14 days
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Voltage-Gated Potassium Channel (VGKC) Antibodies | pmol/L |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
28-Nov-2019
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
VGKC S | 63125VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB | pmol/L |
Test Version
28-Nov-2019